High-quality medicines to treat a range of conditions
In response to the changing needs of the people we serve, we continuously develop our range of medicines, with a focus on differentiated products and delivery systems. Currently, we manufacture hundreds of generic medicines in the US.
Quick Links
Consumer Product Safety Improvement Act and CRC products
Related news
Hikma launches Doxycycline for Injection
25 June 2021
Hikma launches Rufinamide Tablets
24 June 2021